NCT03945448 - Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia | Biotech Hunter

Enrollment

356

Participants

Timeline

Start Date

June 20, 2019

Primary Completion Date

October 31, 2027

Study Completion Date

April 30, 2028

Conditions

Cryptococcal Meningitis

Interventions

DRUG

Single dose liposomal Amphotericin and Fluconazole

Intravenous Single dose of 10mg/kg of Ambisome and fluconazole as per WHO guidelines for six months.

DRUG

Fluconazole

Fluconazole 800mg for 2 weeks,400mg for 8 weeks and 200mg up to six months

Trial Locations (1)

RECRUITING

infectious Disease Institute Kampala,Uganda, Kampala